StockIQpro
NASDAQ:VCEL

Vericel Corp

Vericel Corp's revenue grew 16.5% in fiscal 2025 to $276.3M while operating margin rose to 4.0%, its highest in 10 years. Free cash flow was $24.7M, 9.0% of revenue, and the diluted share count rose 0.9%.Summary generated from Vericel Corp's SEC filings. Latest annual report filed Feb 26, 2026.

Revenue (FY25)$276.3M
Revenue growth+16.5%
Revenue, 5-yr CAGR+17.3%
Gross margin74.4%
Operating margin4.0%
Net margin6.0%
ROICn/a
Return on equity5.1%
Debt / equityn/a
Free cash flow$24.7M
FCF margin9.0%
Share count change+0.9%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue156164198237276
Operating income−8−17−6511
Net income−7−17−31017
Free cash flow211015−625

Recent filings

From SEC EDGAR

Peers

Biological products, (no diagnostic substances)